The prescribing information for Abrysvo ® (respiratory syncytial virus [RSV] vaccine) and Arexvy ® (RSV vaccine, adjuvanted) has been updated to include a new warning regarding the risk of ...
1d
The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information ...
Daniel was diagnosed with Guillain-Barré syndrome, a rare neurological disorder that occurs when a person's immune system ...
The FDA requires labeling changes to the prescribing information for Pfizer and GSK RSV vaccines to include warnings about the risk for GBS.
6hon MSN
Scientists at the Garvan Institute of Medical Research have discovered how a viral infection causes autoimmune disease, ...
As for GBS itself, this neurological ailment can be severe, attacking nerves and warranting hospitalisation for weeks or ...
The FDA has required the manufacturers of the RSV Vaccines Abrysvo and Arexvy to add a new warning to their labels about the ...
According to CDC researchers, cases of tularemia in the U.S. increased by nearly 60% from 2011 to 2022 compared with the ...
ANX005 First Potential Targeted Therapy for Guillain-Barré Syndrome Advancing Towards 1H 2025 BLA SubmissionANX007 First Potential ...
The NHS has been inundated with serious flu cases as more than 5,000 people a day require hospital treatment, and one doctor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback